PM360 2021 Trailblazer Awards Patient/Consumer Education Silver Winner Alexion Pharmaceuticals and Snow Companies

aHUS Journey Patient Resource Kit (Alexion Pharmaceuticals, Snow Companies)

Atypical hemolytic uremic syndrome (aHUS) is a genetic, chronic, and life-threatening ultra-rare disease that can progressively damage vital organs, such as the kidneys.

Generally, patients receive their diagnosis and first treatment in emergency situations and are often overwhelmed, fearful, and uncertain about next steps.

Alexion Pharmaceuticals, in partnership with Snow Companies, designed the aHUS Journey Patient Resource Kit to help aHUS patients navigate this uncertainty with greater confidence. Alongside treatment brochures, the kit contains information on support programs, webinars, community engagements, and opportunities to get involved as a patient advocate.

In parallel with the physical kit, the team launched, a “digital kit” providing access to the same resources through an alternative channel.

Community feedback on the kit has been resoundingly positive. Fittingly, the kit’s PM360 Silver Award recognition was announced on the eve of the 7th Annual aHUS Awareness Day. The team hopes this recognition will help to further awareness for this ultra-rare community.


You May Also Like

PM360 2020 Innovative Company PixCell Medical

PixCell Medical Hanan Ben-Asher, COO and Business Development PixCell Medical has developed the ...

PM360 2021 Trailblazer Awards Pharma/Biotech Company of the Year Moderna

Moderna has a unique opportunity to make a profound impact on global human health ...

PM360 2019 Innovative Product MED Select from Bionical Solutions

MED Select Bionical Solutions Mike Viscel, President MED Select is an innovative engagement ...